May 9, 2014 | Digital Pathology, Instruments & Equipment, Laboratory Instruments & Laboratory Equipment, Laboratory Management and Operations, Laboratory News, Laboratory Pathology
Big Data will play major role as Venter’s team sets out to build world’s largest database of human genotypes, microbiomes and phenotypes
For the second time in recent months, another prominent figure has declared his intention to crack the code of human aging. This time it is scientist and entrepreneur J. Craig Venter, Ph.D., known for his role in sequencing the first whole human genome.
Venter will pursue this goal through a brand new company he launched, called Human Longevity, Inc. (HLI), based in La Jolla, California.
Human Longevity, Inc. Will Compete Against Calico
This is a noteworthy development. Pathologists and clinical laboratory managers already know Venter’s competition in this race is a company called Calico that was founded by several entrepreneurs linked to Google. (more…)
Apr 25, 2014 | Digital Pathology, Instruments & Equipment, Laboratory Management and Operations, Laboratory Operations, Laboratory Pathology
The discovery of dual-purpose condons, called ‘duons’ opens the door to creation of more precise diagnostic and medical laboratory tests, as well as better treatment choices
New insights into the human genome have led to the discovery of a second “code” or “language” within human DNA. Pathologists performing genetic testing will be particularly interested in the implications of this discovery, which the researchers have dubbed “duons.”
It was a research team at the University of Washington (UW) that discovered evidence of a second type of DNA code overlying the protein code that controls transcription factors (TFs). TFs regulate flow of genetic information from DNA to messenger RNA, which manages the synthesis of proteins described by the DNA. (more…)
Apr 26, 2013 | Instruments & Equipment, Laboratory News, Laboratory Pathology
Pathologists and clinical laboratory managers may want to learn more about the UCheck mobile app developed by Biosense Technologies
Developers of a new iPhone application claim their app can analyze a urine specimen for up to 25 different diseases. This mobile app is a deliberate attempt to give consumers the ability to perform diagnostic tests that would normally be run in a full-scale clinical laboratory.
Pathologists and clinical biochemists will want to visit the website of Biosense Technologies to check out this mobile application, which is called uCheck. Biosense is a medical device company located in Mumbai, India. (more…)
Dec 7, 2012 | Coding, Billing, and Collections, Instruments & Equipment, Laboratory Instruments & Laboratory Equipment, Laboratory News, Laboratory Pathology
Pathologists and clinical laboratory managers can expect to see new technology translated to a wide variety of diagnostic tests
Researchers claim a new diagnostic technology for detecting the HIV virus is 10 times more sensitive than traditional techniques. More remarkable is the fact that this new technology enables analyte detection at very low concentrations with the naked eye!
Pathologists and clinical laboratory managers won’t see this technology enter clinical use for some time. That is because the developers hope to deploy the accurate, fast, and very cheap HIV medical laboratory tests in Africa first. Once validated in actual clinical use, this radically innovative technology could be adapted for use in a wide variety of clinical laboratory tests.
Scientists at the London Centre for Nanotechnology at Imperial College London (ICL) developed the prototype biosensing mechanism, according to a press release published by EurekAlert!. They claim that the qualitative visual sensor technology is 10 times more sensitive than the current gold standard methods for measuring biomarkers. (more…)
Oct 24, 2012 | Digital Pathology, Laboratory Management and Operations, Laboratory News, Laboratory Operations, Laboratory Pathology
Pathologists and clinical laboratory directors can learn from other industries about how to better achieve quality and cost goals
Why are pathology groups, clinical laboratories, and the majority of healthcare providers so slow to borrow innovative approaches from commercial businesses that measurably improve patient service, quality, and satisfaction? No less an authority than, the Institute of Medicine (IOM) has taken the entire healthcare system to task for being so slow to adopt proven innovations that are being rapidly taken up by non-healthcare industries.
These findings were published in a report recently issued by the Institute of Medicine. Authors of the report found that when it comes to quality, outcomes, cost, and equity, healthcare falls short when compared to other industries. (more…)
